钆贝葡胺
Records for this ingredient, by country (identity only).
ATC V08CA · 1 markets · 13 records
CN 13 records · 6 shown of 6
- 7,935 mg/15 mLinjection莫迪司钆贝葡胺Manufacturer: 上海司太立制药有限公司
- 5,290 mg/10 mLinjection莫迪司钆贝葡胺Manufacturer: 北京北陆药业股份有限公司
- 15 mL per mL / per unit basis not statedinjection莫迪司钆贝葡胺Manufacturer: 海南倍特药业有限公司
- 20 mL per mL / per unit basis not statedinjection莫迪司钆贝葡胺
- 10 mL per mL / per unit basis not statedinjection莫迪司钆贝葡胺
- 10,580 mg/20 mLinjection莫迪司钆贝葡胺Manufacturer: 上海司太立制药有限公司
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.